María Dolores Arenas Jimenez

Dr. María Dolores Arenas Jimenez

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
MJMaría Dolores Arenas Jimenez
María Dolores Arenas Jimenez
Julia Audije-GilJulia Audije-Gil
Julia Audije-Gil
RMRodrigo Martínez
Rodrigo Martínez
NVNatalia Martín Vaquero
Natalia Martín Vaquero
MGMiquel Gómez
Miquel Gómez
MAMarta Arias
Marta Arias
Background: The burden of chronic kidney disease is increasing, driven by population aging and the increase in risk factors. In-centre haemodialysis (HD), which accounts for most of the environmental impact of kidney replacement therapy, is a power-hungry, water-hungry and a waste-generating intervention. Methods: Here we characterize the environmental impact of 20 HD centres over 5 years and its modulation by operational changes (centre size, opening days, geographic location, type of water treatment plant and disinfection, dialysis modalities such as HD versus haemodiafiltration, seasonal variations and the impact of various corrective actions throughout time). Results: Average water and energy consumption per session were lower in larger centres compared with smaller ones, as well as in centres that operated daily compared with those that opened three times a week (both P < .05). Seasonality, which depends on the geographic region, had a marked influence (P < .001) on water and energy consumption, as does the choice of water treatment plant (P < .001). Actions taken in certain centres significantly reduced energy consumption up to 30%, plastic waste up to 65% and hazardous waste up to 63%. Conclusion: Annual monitoring must be performed to detect variations and plans must be designed to reduce the environmental impact. As it is not possible to reduce HD water and energy consumption to zero, implementing targeted actions offers a promising strategy for reducing the environmental burden.

13 November 2024 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
CSClara Sanz-García
Clara Sanz-García
MRMinerva Rodríguez-García
Minerva Rodríguez-García
JGJose Luis Gorriz
Jose Luis Gorriz
BCBeatriz Martín Carro
Beatriz Martín Carro
JFJürgen Floege
Jürgen Floege
LMLeo Marosi
Leo Marosi
Ageing often affects biomarker production. Yet, clinical/optimal thresholds to guide clinical decisions do not consider this. Serum albumin decreases with age, but hypoalbuminaemia is defined as serum albumin 75 years, respectively (reference ≤55 years; P value for trend: <0.001)]. Survival analysis showed that the association between hypoalbuminaemia and mortality was weaker in patients aged ≥65 compared to <65 years [hazard ratios: 1.36(95%CI: 1.17–1.57) and 1.81(95%CI:1.42–2.31) respectively; P value for interaction 0.004]. The ability of albumin levels to predict mortality was consistently higher in younger patients. Optimal albumin thresholds for predicting mortality were 3.7 g/dl in patients younger than 65 years and 3.5 g/dl in patients 65 years and older. Ageing is accompanied by lower albumin levels, and the association between hypoalbuminaemia and mortality may be modified by age. Different clinical thresholds that consider age may better discriminate risks associated with hypoalbuminaemia.

1 July 2025 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
SGSolmar Rodríguez de Galvis
Solmar Rodríguez de Galvis
ERElena Guerrero Rodríguez
Elena Guerrero Rodríguez
Julia Audije-GilJulia Audije-Gil
Julia Audije-Gil
SHSandra Hernández Hernández
Sandra Hernández Hernández
MAMarta Argilés-Huguet
Marta Argilés-Huguet
MJMaría Dolores Arenas Jimenez
María Dolores Arenas Jimenez
Background: Virtual reality (VR) helps control symptoms during procedures in chronic patients. This study analyzes VR’s effect on pain and anxiety in hemodialysis (HD) patients at two points: the vascular access puncture and disconnection. Methods: A prospective, non-randomized, crossover, multicenter pilot study assessing pre- and post-intervention outcomes with VR headsets. The intervention group used VR for up to 13 sessions, around the puncture, and at the end of the session. Pain was measured with the Faces Pain Scale - Revised (FPS-R) and anxiety with the Visual Analogue Scale for Anxiety (VAS-A). Usability and patient satisfaction with VR were also evaluated. Results: A total of 73 patients (66.2 ± 13.3 years, 67% men) were included. At the start, 8.2% declined to wear the VR headset. The average number of sessions with the headset was 6.5 ± 4.8, with 23.3% completing all 13 sessions. Pain during punctures significantly improved with VR (1.26 vs 0.97; p = 0.039), while anxiety improved non-significantly. Anxiety during disconnection slightly increased, but also not significantly. Patients with higher initial pain and anxiety levels during puncture and disconnection showed significant improvement, while those with lower initial levels worsened (p < 0.05 in all cases). The HD population showed varying levels of acceptance of VR. Conclusion: VR headsets help reduce pain during punctures, especially in patients with more intense pain. The effect on anxiety reduction during punctures or at the end of the session is inconclusive, with better results in those with higher anxiety levels. VR acceptance in the HD population is variable.

30 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAna Casaux-Huertas
Ana Casaux-Huertas
MSMaria Luz Sanchez-Tocino
Maria Luz Sanchez-Tocino
MJMarta San Juan-Miguelsanz
Marta San Juan-Miguelsanz
Julia Audije-GilJulia Audije-Gil
Julia Audije-Gil
NRNeydu Romero-Lugo
Neydu Romero-Lugo
FEFRAGILDIAL Working Group, Fundación Renal Española
FRAGILDIAL Working Group, Fundación Renal Española
Post-dialysis fatigue is one of the most frequent and limiting symptoms among patients undergoing hemodialysis (HD), characterized by intense physical exhaustion that may persist beyond the treatment session. Sleep disturbances frequently coexist with fatigue and may contribute to overall symptom burden. Nutritional status has been identified as a potential determinant of fatigue severity. Understanding these relationships may help identify associated factors and guide multidisciplinary interventions. Objectives: To assess the prevalence and intensity of fatigue in patients receiving HD, to describe the burden of sleep disturbances, and to analyze their association with nutritional status and various clinical, dialytic, and sociodemographic variables. Methods: A cross-sectional descriptive study was conducted between November and December 2024 in adults with chronic kidney disease undergoing maintenance HD. Fatigue and sleep disturbances were assessed using brief patient-reported outcome items adapted from PROMIS item bank concepts and analyzed as separate subscales. Nutritional status was evaluated using the Mini Nutritional Assessment–Short Form (MNA-SF). Sociodemographic, clinical, dialytic, and laboratory variables were collected. Statistical analyses were performed using SPSS v29, applying association and correlation tests (p ≤ 0.05). Results: A total of 729 patients were included (67.1% men), with a mean age of 67.7 ± 14.5 years. Clinically relevant fatigue was reported by approximately 50% of participants, with around 20% presenting severe fatigue. Sleep disturbances affected nearly 60% of patients, with severe impairment reported in approximately 30%. Regarding nutritional status, 61.9% had normal nutrition, 33.2% were at risk of malnutrition, and 4.9% were malnourished. Fatigue was significantly associated with female sex (p < 0.001), longer time on hemodialysis (p < 0.001), greater weekly dialysis exposure (p = 0.012), and poorer nutritional status (p = 0.003). The absence of residual urine output showed a borderline association with fatigue (p = 0.059) but was significantly associated with sleep disturbances (p = 0.002). Sleep disturbance scores were also significantly associated with lower levels of albumin, total proteins, and transferrin. No associations were observed between fatigue and age, BMI, comorbidity, ultrafiltration rate, or biochemical parameters. Conclusions: Fatigue is a highly prevalent and clinically relevant symptom in patients undergoing HD and is closely associated with nutritional status and dialysis-related factors. Sleep disturbances are also highly prevalent and may act as an important modulating factor, potentially amplifying fatigue, particularly in patients with greater biological vulnerability or loss of residual kidney function. The systematic use of patient-reported outcome measures (PROMs) to assess fatigue and sleep, together with nutritional evaluation, may facilitate the early identification of vulnerable patients and guide targeted strategies to reduce symptom burden and improve quality of life.

26 November 2025 in Nefrología (English Edition)
Verified
Journal Article
Open access
MJMaría Dolores Arenas Jimenez
María Dolores Arenas Jimenez
JAJulia Audije-Gil
Julia Audije-Gil
PMPaula Manso
Paula Manso
DHDavid Hernán
David Hernán
FDFabiola Dapena
Fabiola Dapena
CSCristina Sanz
Cristina Sanz

30 September 2023 in Enfermería Nefrológica
Verified
Journal Article
Open access
PDF file
David Hernán-GascueñaDavid Hernán-Gascueña
David Hernán-Gascueña
MJMaría Dolores Arenas Jimenez
María Dolores Arenas Jimenez
MPMónica Pereira-García
Mónica Pereira-García
CLCristina Ledesma-Torre
Cristina Ledesma-Torre
AIAdriana Iglesias-González
Adriana Iglesias-González
DPDolores Piña-Simón
Dolores Piña-Simón
Introduction: In addition to the consequences of SARS-CoV-2 infection in renal patients, maintaining dialysis activity during the pandemic has been a significant challenge due to staff shortages resulting from illness-related absences. Objective: To analyze the incidence of COVID-19 infections among hemodialysis professionals, their characteristics, and their impact on work absences during different waves of the pandemic. Material and Method: Longitudinal observational study conducted from March 3, 2020, to April 23, 2022 (776 days), involving an average of 406 healthcare and non-healthcare professionals from 18 dialysis units and two administrative support units of the Iñigo Álvarez de Toledo Renal Foundation. Data collection was carried out through communication from various supervisors to the human resources department. Results: During the study period, 179 professionals out of an average of 406 (44.1%) became infected. Among these, 52% were nurses, 25% were nursing assistants, 11% were nephrologists, and 12% were other professionals. 40.2% of cases exhibited symptoms. A total of 160 infected individuals were absent from work due to illness (89.3%), with an average duration of 15.9 ± 14.3 days. In 71.6% of cases, close contacts were identified outside the dialysis units, and this contact identification increased with each wave of the pandemic, rising from 6.7% in the 1st wave to 40% in the 6th wave (p=0.016). Conclusions: The symptoms have generally been mild, with absences from work lasting at least two weeks. Close contacts were mainly identified within the community, and there were no recorded infections transmitted through renal patients in the units.